Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ HotCopper Highlights: DroneShield, tungsten and lithium stocks dominate this week′s investor chatter (Market Herald) +++ DRONESHIELD Aktie -3,02%

IQVIA Aktie

 >IQVIA Aktienkurs 
209.35 EUR    (TradegateBSX)
Ask: 210.9 EUR / 48 Stück
Bid: 207.8 EUR / 49 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
IQVIA Aktie über LYNX handeln
>IQVIA Performance
1 Woche: +3,2%
1 Monat: +13,9%
3 Monate: +41,6%
6 Monate: +47,4%
1 Jahr: +31,2%
laufendes Jahr: +7,6%
>IQVIA Aktie
Name:  IQVIA HLDGS DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US46266C1053 / A2JSPM
Symbol/ Ticker:  QTS (Frankfurt) / IQV (NYSE)
Kürzel:  FRA:QTS, ETR:QTS, QTS:GR, NYSE:IQV
Index:  S&P500
Profil:  IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The company supports pharmaceutical, biotechnology, medical device, and healthcare organizations in de..
>Volltext..
Marktkapitalisierung:  34502.75 Mio. EUR
Unternehmenswert:  47006.56 Mio. EUR
Umsatz:  14731.47 Mio. EUR
EBITDA:  3074.29 Mio. EUR
Nettogewinn:  1192.43 Mio. EUR
Gewinn je Aktie:  7.06 EUR
Schulden:  14084.52 Mio. EUR
Liquide Mittel:  1655.52 Mio. EUR
Operativer Cashflow:  2444.69 Mio. EUR
Bargeldquote:  0.24
Umsatzwachstum:  11.62%
Gewinnwachstum:  14.65%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel 5 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 25.305.574 Euro.
Suchwörter:  IQVIA
Letzte Datenerhebung:  14.08.26
>IQVIA Kennzahlen
Aktien/ Unternehmen:
Aktien: 164.6 Mio. St.
Frei handelbar: 99.02%
Rückkaufquote: 2.92%
Mitarbeiter: 93000
Umsatz/Mitarb.: 0.15 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 13.98%
Bewertung:
KGV: 29.68
KGV lG: 18.62
KUV: 2.35
KBV: 6.38
PEG-Ratio: 1.76
EV/EBITDA: 15.29
Rentabilität:
Bruttomarge: 26.02%
Gewinnmarge: 8.09%
Operative Marge: 13.9%
Managementeffizenz:
Gesamtkaprendite: 4.7%
Eigenkaprendite: 23.01%
 >IQVIA Anleihen 
>IQVIA Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
13.08.26 - 16:09
Clinilabs Announces Leadership Expansion and Welcomes Laura Shannon as Chief Executive Officer and Promotion of Founder Gary Zammit, Ph.D., to Executive Chairperson (Business Wire)
 
EATONTOWN, N.J.--(BUSINESS WIRE)--Clinilabs, a leading specialty contract research organization (CRO) focused on central nervous system (CNS) drug and device development, today announced leadership expansion. Laura Shannon joins the organization as Chief Executive Officer as Gary Zammit, Ph.D., the Company's founder, assumes the role of Executive Chairperson. This expansion of the senior leadership team is a recognition of a growing organization with global capabilities and continuing commitment to advancing treatments for patients with psychiatric and neurological disorders. Ms. Shannon is a dynamic leader with more than 30 years of biopharma industry experience, known for her ability to build high-performing teams, forge strategic alliances, and drive growth across complex organizations. Most recently serving as EVP and Chief Commercial Officer of the US and Canada regional business units at IQVIA, where she led a nationwide multibillion-dollar sales and account management team across R&D, Real World S...
12.08.26 - 16:45
IQV Stock Gains 42% in 3 Months: Here′s What You Should Know (Zacks)
 
IQVIA shares jump 41.5% in three months as record R&DS bookings, a solid backlog, raised 2026 guidance and share buybacks support sentiment....
06.08.26 - 13:33
Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update (PR Newswire)
 
Achieved $31.7 million in second quarter 2026 total revenue, including $23.2 million in net product revenue for IBTROZI® (taletrectinib) IBTROZI is the most prescribed ROS1 TKI in in both first-line and overall new patient starts in 2026 based on IQVIA claims from first five months of the......
05.08.26 - 05:01
Insiderhandel: Vorstand verkauft Aktien von IQVIA Holdings im Wert von 436426 USD (Insiderkauf)
 
Patel, Bhavik - Vorstand - Tag der Transaktion: 2026-07-31...
05.08.26 - 05:01
Insiderhandel: Vorstand verkauft Aktien von IQVIA Holdings im Wert von 1279740 USD (Insiderkauf)
 
Staub, W Richard - Vorstand - Tag der Transaktion: 2026-08-03...
04.08.26 - 20:30
Is IQVIA Stock a Buy as Growth Improves but High Leverage Persists? (Zacks)
 
IQV's proprietary data platform and expanding clinical research business support growth, but high debt and liquidity risks keep the investment outlook balanced....
02.08.26 - 22:24
An IQVIA Insider Sold Just Before the Stock Slipped. Here′s What Long-Term Investors Should Know (Fool)
 
This insider disposed of 16% of direct holdings at $245.21 per share, while maintaining nearly 3,000 shares valued at $740,000....
02.08.26 - 22:12
An IQVIA Insider Just Sold Over $1 Million in Stock. Here′s What Long-Term Investors Should Know (Fool)
 
Sherbet's disposition leaves him with 20,999 directly held shares valued at $5.2 million as IQVIA trades near $238....
02.08.26 - 22:00
An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion (Fool)
 
Bousbib exercised expiring stock appreciation rights while maintaining about 1.4 million shares in total beneficial ownership....
01.08.26 - 02:01
Insiderhandel: Vorstand verkauft Aktien von IQVIA Holdings im Wert von 1245800 USD (Insiderkauf)
 
Sherbet, Eric - Vorstand - Tag der Transaktion: 2026-07-29...
01.08.26 - 02:01
Insiderhandel: Vorstand verkauft Aktien von IQVIA Holdings im Wert von 136827 USD (Insiderkauf)
 
Cherofsky, Keriann - Vorstand - Tag der Transaktion: 2026-07-29...
01.08.26 - 02:01
Insiderhandel: Vorstand verkauft Aktien von IQVIA Holdings im Wert von 26092072 USD (Insiderkauf)
 
Bousbib, Ari - Vorstand - Tag der Transaktion: 2026-07-29...
29.07.26 - 04:45
IQVIA (IQV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
 
The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....
28.07.26 - 19:30
Stocks making the biggest moves midday: Boeing, Amkor, Corning, Sandisk, Iqvia & more (CNBC)
 
Here are some of the companies making headlines in midday trading....
28.07.26 - 18:15
IQV Q2 Earnings Beat Estimates on R&D Bookings, Guidance Raised (Zacks)
 
IQVIA's Q2 earnings beat estimates as record R&D bookings, broad-based growth and stronger demand support a raised 2026 outlook....
28.07.26 - 16:57
ICON plc rises after Anthropic deal, Iqvia earnings (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.07.26 - 16:00
IQVIA Holdings (IQV) Q2 Earnings and Revenues Beat Estimates (Zacks)
 
IQVIA (IQV) delivered earnings and revenue surprises of +4.31% and +1.63%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?...
28.07.26 - 15:33
IQVIA surges on Q2 beat and guidance hike (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.07.26 - 15:06
ROUNDUP: IQVIA Holdings Boosts FY26 Outlook; Shares Surge 10.6% (AFX)
 
WASHINGTON (dpa-AFX) - While reporting financial results for the second quarter on Tuesday, life sciences services company IQVIA Holdings Inc. (IQV) raised its adjusted earnings and revenue guidan......
28.07.26 - 13:42
IQVIA Holdings Inc. Q2 Income Drops (AFX)
 
WASHINGTON (dpa-AFX) - IQVIA Holdings Inc. (IQV) released a profit for second quarter that Drops, from the same period last yearThe company's bottom line totaled $256 million, or $1.53 per share. ......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein Hafen ist ein reizvoller Aufenthalt für eine im Lebenskampf erschöpfte Seele. - Charles Baudelaire
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!